1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Congestive Heart Failure - Pipeline Analysis

Congestive Heart Failure - Pipeline Analysis

  • May 2015
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 95 pages

“Congestive Heart Failure (CHF) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CHF. The report covers all the drugs being developed in various development phases (Discovery to Phase 2 clinical). The pipeline focuses on disease modification and includes pharmacologic drugs, gene therapy, stem cell therapy and RNA-based therapeutics, but excludes symptom relief drugs like diuretics, acute treatments, angiotensins or thrombin inhibitors etc. The report also covers some of the hot targets in research for CHF treatments.

This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative opportunities in the CHF Drug market. The report also provide strategic insights on medicines that are likely to have an impact on CHF treatment space and potentially alter standards of care in CHF in the foreseeable future.
Current therapies focuses only to slow down the progression of the disease as more number of molecules are symptom relieving drugs, hence it provides a tremendous opportunity for upcoming therapies specific to CHF such as gene-based, stem cell-based and miRNA-based therapies, which reverses disease course and reduce the number of cardiac events.

Table Of Contents

Congestive Heart Failure - Pipeline Analysis
• Causes and Symptoms
• Diagnosis
• Classification
• Compensatory mechanisms
• Unmet needs
• Prevalence
• Incidence
• Hospitalizations
• Re-admissions
• Forecasting model
• Market dynamics
• Market sizing
• Cost burden
• Development stage
• Modalities
• Leading players
• Innovative approaches
• Associated targets
• Pipeline
• Competitive landscape
• Pipeline
• Competitive landscape
• mi-RNA
• m-RNA
• Pipeline
• Competitive landscape
DRUGS (small molecules, recombinant proteins,
growth factors)
• Pipeline
• Competitive landscape
• Company Profiles
• Overview, Pipeline and Deals

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Trends in Gene Therapy

Trends in Gene Therapy

  • $ 5000
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

The number of gene therapy products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015. Additionally, three gene therapy products have received regulatory approval ...

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

Integrase Inhibitors -Pipeline Insights, 2016

Integrase Inhibitors -Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Integrase Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Integrase Inhibitors. The ...


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.